TrianglePUBLICATIONS · 30811293
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2019 Apr 20
- First author
- Flinn IW
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Flinn IW
- type
- Author
- name
- van der Jagt R
- type
- Author
- name
- Kahl B
- type
- Author
- name
- Wood P
- type
- Author
- name
- Hawkins T
- type
- Author
- name
- MacDonald D
- type
- Author
- name
- Simpson D
- type
- Author
- name
- Kolibaba K
- type
- Author
- name
- Issa S
- type
- Author
- name
- Chang J
- type
- Author
- name
- Trotman J
- type
- Author
- name
- Hallman D
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Flinn IW
- type
- Author
- name
- van der Jagt R
- type
- Author
- name
- Kahl B
- type
- Author
- name
- Wood P
- type
- Author
- name
- Hawkins T
- type
- Author
- name
- MacDonald D
- type
- Author
- name
- Simpson D
- type
- Author
- name
- Kolibaba K
- type
- Author
- name
- Issa S
- type
- Author
- name
- Chang J
- type
- Author
- name
- Trotman J
- type
- Author
- name
- Hallman D
- type
- Author
- bibliography ids
- nci-bib-35a19b63c9d729ffb587bba6
- book metadata
- content sha256
- f8764905a8d4bbfdcf427f2e394feaafdceaeaaabd0211f5c0ffc3f90fd2f220
- document type
- citation
- dois
- 10.1200/JCO.18.00605
- electronic publication date
- display
- 2019 Feb 27
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30811293
- immutable id
- pubmed:30811293@f8764905a8d4bbfdcf427f2e394feaafdceaeaaabd0211f5c0ffc3f90fd2f220
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 12
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 984-991
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30811293
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 979feeb1f4d3b1d49b4044d4fee791adadd1cea0b4e9225f14a306ec0fa600aa
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Apr 20
- precision
- day
- year
- 2019
- publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.
Preserved source evidence · Independent clinical review pending · Not medical advice